The equity capital markets are experiencing a meaningful improvement in issuance conditions as 2025 progresses. The CBOE Volatility Index (VIX) has settled into a range of 13–17, equity indices are trading near all-time highs, and institutional investor appetite for new paper has recovered substantially from the risk-off posture that characterized much of 2022 and 2023. For companies that have been waiting for the right moment to access public markets, the window is opening — but it requires careful navigation.
The IPO market's recovery is not uniform. Investors have become significantly more discerning following the 2021 vintage of high-profile listings that subsequently collapsed in value. Companies that priced at 30–50x forward revenue during the SPAC and growth-at-any-cost era have, in many cases, traded down 60–80% from their offering prices. This experience has recalibrated institutional expectations: profitability, or a credible near-term path to it, is now a prerequisite rather than an aspiration for successful public market entry.
The Anatomy of the Current IPO Market
Year-to-date 2025 IPO proceeds on US exchanges are tracking approximately 35% above the same period in 2024, with the technology, healthcare, and financial services sectors accounting for the majority of issuance. The average first-day return for 2025 IPOs has been approximately 12%, compared to a negative average for the 2022–2023 cohort — a signal that the market is clearing at prices that leave adequate upside for public market investors.
The quality bar for IPO candidates has risen materially. Underwriters are applying more rigorous screening criteria, and institutional investors — who have seen their IPO allocations generate negative returns in aggregate over the past three years — are demanding higher standards of financial disclosure, management credibility, and competitive differentiation. Companies that cannot articulate a compelling, evidence-based growth narrative with clear unit economics will struggle to build the institutional book required for a successful offering.
The geographic distribution of IPO activity is also notable. While the NYSE and Nasdaq remain the premier venues for large-cap technology and healthcare listings, the London Stock Exchange has been actively competing for international issuers following a period of relative underperformance. The LSE's reforms to its listing rules — including the elimination of the premium/standard segment distinction and the relaxation of free float requirements — are beginning to attract renewed interest from European and Asian companies considering London as a primary or secondary listing venue.
Key Factors Issuers Must Evaluate
Valuation Anchoring and Comparable Company Analysis. The most consequential decision in any IPO process is the initial valuation framework. Issuers and their advisors must construct a defensible comparable company analysis that accounts for the current multiple environment, not the peak multiples of 2021. Revenue multiples for high-growth software companies have compressed from 20–40x to 8–15x; healthcare services companies are trading at 12–18x EBITDA; and consumer-facing businesses are being valued primarily on free cash flow generation. Anchoring to stale comparables is a recipe for a broken deal.
Investor Education and the Roadshow. The institutional roadshow remains the critical mechanism for building conviction among the long-only funds and hedge funds that will anchor the book. Management teams must be prepared to address the hard questions: What is the sustainable competitive advantage? How does the company defend its market position against well-capitalized incumbents and disruptive new entrants? What is the capital allocation philosophy post-IPO? How does management think about the path to profitability, and what are the key operating leverage inflection points?
Lock-Up Structures and Insider Selling. The post-IPO trading dynamics are heavily influenced by lock-up expiration schedules and the extent to which insiders are selling at the IPO. Institutional investors are acutely sensitive to situations where founders, early-stage investors, or management teams are using the IPO primarily as a liquidity event. Companies where the primary use of proceeds is balance sheet strengthening for growth investment — rather than insider liquidity — consistently achieve better aftermarket performance.
Governance and ESG Disclosure. Institutional investors, particularly large asset managers operating under ESG mandates, are applying increasing scrutiny to governance structures at the time of IPO. Dual-class share structures that concentrate voting power with founders are still accepted in the technology sector, but they require careful explanation and, increasingly, sunset provisions. Board composition, executive compensation philosophy, and climate-related financial disclosures are all subject to heightened investor attention.
The Follow-On and Convertible Markets
While IPOs capture the most attention, the follow-on equity and convertible note markets are equally important components of the equity capital markets ecosystem. Follow-on offerings by recently public companies have been particularly active in 2025, as companies that priced their IPOs conservatively are returning to the market to raise additional capital at improved valuations. The average follow-on offering in 2025 has been priced at a discount of approximately 3–5% to the prevailing market price — a significant improvement from the 7–10% discounts that were required in 2023.
The convertible note market has experienced a renaissance, driven by the combination of higher interest rates (which make the embedded optionality more valuable) and equity market volatility (which increases the value of the conversion feature). Investment-grade and sub-investment-grade issuers alike are finding the convertible market an attractive source of capital, particularly for companies with strong equity stories that want to minimize dilution while accessing growth capital at below-market coupon rates.
Block trades — accelerated secondary offerings executed overnight without a traditional roadshow — have also been a significant feature of the 2025 market. As PE sponsors and corporate insiders seek to monetize positions, the block trade market has demonstrated impressive depth, with transactions of $500 million to $2 billion+ being executed efficiently when the underlying equity story is compelling and the discount to market is appropriately calibrated.
Capital Markets Perspective
The companies that will achieve the best outcomes in the current IPO market are those that have done the work before the process begins: clean financial statements with at least three years of audited history, a well-articulated equity story that resonates with institutional investors, a management team with public company experience or credible advisors who can bridge the gap, and a realistic valuation expectation that prices in the current multiple environment rather than the peak. The window is open — but it rewards preparation.
Looking Ahead: The H2 2025 Pipeline
The pipeline of companies preparing for public market entry in H2 2025 is substantial. Several high-profile technology companies — including AI-native platforms, fintech disruptors, and healthcare technology companies — are in advanced preparation stages. The aggregate implied market capitalization of the known pipeline exceeds $150 billion, suggesting that if market conditions remain supportive, 2025 could be the most active IPO year since 2021.
The key risk to this constructive outlook is macro volatility. A significant deterioration in the economic outlook, a resurgence of inflation that forces the Federal Reserve to reverse course on rate cuts, or a geopolitical shock that triggers a risk-off episode could rapidly close the window. Issuers with near-term capital needs should not assume that current conditions will persist indefinitely; the cost of waiting for a "perfect" market is often higher than the cost of executing in a "good" market.
Disclaimer: This article is published for informational purposes only and does not constitute investment advice, a solicitation, or an offer to buy or sell any securities. The views expressed represent the analytical perspectives of Alpha Beta Capital's advisory team and are subject to change without notice.
© 2025 Alpha Beta Capital. All rights reserved.